Trinity Biotech (TRIB) Short term Debt (2022 - 2025)

Trinity Biotech's Short term Debt history runs 4 years deep, the most recent figure standing at $1.1 million for Q2 2025.

• In Q2 2025, Short term Debt fell 22.85% year-over-year to $1.1 million; the TTM figure through Jun 2025 stood at $1.1 million (down 22.85% YoY), while the FY2024 annual figure was $1.7 million, up 215.21% from the prior year.
• Short term Debt came in at $1.1 million for Q2 2025 at Trinity Biotech, down from $1.7 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $2.0 million in Q2 2022 to a low of $526000.0 in Q4 2023.
• A 4-year average of $1.3 million and a median of $1.4 million in 2024 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt surged 215.21% in 2024 and slipped 22.85% in 2025, its largest moves.
• Trinity Biotech's Short term Debt stood at $2.0 million in 2022, then plunged by 73.73% to $526000.0 in 2023, then soared by 215.21% to $1.7 million in 2024, then tumbled by 32.81% to $1.1 million in 2025.
• According to Business Quant data, Short term Debt over the past three periods registered $1.1 million, $1.7 million, and $1.4 million for Q2 2025, Q4 2024, and Q2 2024 respectively.

Peer Comparison